I. K. . Sari, “Preclinical Evaluation of HPV Type 52 L1L2 Chimeric Protein as a Cervical Cancer Vaccine Candidate”, HAYATI J Biosci, vol. 33, no. 3, pp. 556–565, Dec. 2025, doi: 10.4308/hjb.33.3.556-565.